基本信息
浏览量:3
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Graham Pockley is the CEO of multimmune GmbH, Munich, professor emeritus of Immunobiology and the former Director of the John van Geest Cancer Research Centre at Nottingham Trent University, UK, and also the Chief Scientific Officer (interim) of Alphageneron Pharmaceuticals Inc. USA. He was also the Founder and CEO of the flow cytometry resource Chromocyte.
Professor Pockley is focussed on the development of new immunotherapeutic strategies for treating aggressive and 'orphan' cancers, and new approaches for analysing and interpreting complex datasets and defining new biomarkers of disease presence, status and response to therapy in patients with cancer.
multimmune GmbH is a private, clinical-stage biopharmaceutical company which has developed a unique and proprietary technology platform on the basis of the founding scientists' (Professor Gabriele Multhoff, Dr Claus Botzler) discovery that cell surface-bound Hsp70 is uniquely expressed on a large proportion of cancers (~50-75%), but not on healthy cells. This makes this form of Hsp70 an excellent and broadly-applicable molecule on which to base the development of innovative therapeutics and diagnostics ('theranostics').
Specialties:
Development of cancer theranostics
Immunoregulatory mechanisms in health and disease
Immunobiology of heat shock (stress) proteins
Cancer Immunotherapies
Multi-parameter flow cytometry
Flow cytometry functional assays
Immunoassay development
Cell-based assays
Professor Pockley has published over 200 articles and in 2019 PLOS Biology (https://doi.org/10.1371/journal.pbio.3000384) identified Professor Pockley as being in the top 0.5% (in terms of citation impact) of the ~6.9 million scientists that have published at least 5 papers since 1995 across all disciplines.
研究兴趣
论文共 335 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Mina Yazdi,Morteza Hasanzadeh Kafshgari, Fatemeh Khademi Moghadam,Vahid Zarezade,Rupert Oellinger,Mohammad Khosravi, Stefan Haas,Cosima C. Hoch,Alan Graham Pockley,Ernst Wagner,Barbara Wollenberg,Gabriele Multhoff,
ADVANCED SCIENCEno. 14 (2024): e2305998-e2305998
James O. Lindsay,Daniel Hind,Lizzie Swaby,Hannah Berntsson,Mike Bradburn, C. Uday Bannur,Jennifer Byrne,Christopher Clarke, Lauren Desoysa, Ben Dickins,Shahida Din,Richard Emsley,
LANCET GASTROENTEROLOGY & HEPATOLOGYno. 4 (2024): 333-345
James O Lindsay,Daniel Hind,Lizzie Swaby,Hannah Berntsson,Mike Bradburn, Uday Bannur C,Jennifer Byrne,Christopher Clarke, Lauren Desoysa, Ben Dickins,Shahida Din,Richard Emsley,
James O Lindsay,Daniel Hind,Lizzie Swaby,Hannah Berntsson,Mike Bradburn, Uday Bannur C,Jennifer Byrne,Christopher Clarke, Lauren Desoysa,Shahida Din,Richard Emsley,Gemma A Foulds,
Efficacy and Mechanism Evaluationno. 03 (2024)
Joshua R. D. Pearson, Carles Puig-Saenz, Jubini E. Thomas, Lydia D. Hardowar,Murrium Ahmad, Louise C. Wainwright, Adam M. McVicar,Victoria A. Brentville, Chris J. Tinsley,A. Graham Pockley,Lindy G. Durrant,Stephanie E. B. McArdle
Joshua R D Pearson, Carles Puig-Saenz, Jubini E Thomas, Lydia D Hardowar,Murrium Ahmad, Louise C Wainwright, Adam M McVicar,Victoria A Brentville, Chris J Tinsley,A Graham Pockley, Lindy G Durrant,Stephanie E B McArdle
Amy Kwan,Natalie Winder, Emer Atkinson,Haider Al-Janabi,Richard J. Allen,Russell Hughes, Mohammed Moamin, Rikah Louie, Dhanajay Evans, Matthew Hutchinson, Drew Capper,Katie Cox,
crossref(2023)
Alexia Xanthopoulos,Ann-Kathrin Samt, Christiane Guder,Nicholas Taylor, Erika Roberts, Hannah Herf, Verena Messner, Anskar Trill,Katharina Larissa Kreszentia Holzmann,Marion Kiechle,Vanadin Seifert-Klauss,Sebastian Zschaeck,
Methods in molecular biology (Clifton, N.J.) (2023): 307-324
VA Brentville,M Vankemmelbeke, RL Metheringham, P Symonds,KW Cook,RA Urbanowicz,T Tsoleridis, CM Coleman, K-C Chang, A Skinner, E Dubinina, I Daniels,
bioRxiv (Cold Spring Harbor Laboratory)no. 02 (2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn